跳至主要内容
临床试验/NCT05562622
NCT05562622进行中(未招募)不适用

Clinical Assessment of DOT Spectacle Lenses in Chinese Children

SightGlass Vision, Inc.5 个研究点 分布在 1 个国家目标入组 195 人开始时间: 2023年2月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
195
试验地点
5
主要终点
Axial length

研究概览

简要总结

This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of myopia in children of Chinese origin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Evaluator/Investigational site staff tasked with measuring key primary variables (i.e., axial length and SER) will be masked.

入排标准

年龄范围
6 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children 6-13 years of age
  • SER error between -0.75D and -5.00D
  • Willingness to wear study spectacles and participate in the trial for 12 months without contact lens wear

排除标准

  • Prior usage of atropine, multifocal contact lenses, or orthokeratology (ortho-K)
  • Astigmatism worse than -1.50 DC (by manifest refraction) in either eye
  • Anisometropia (SER manifest refraction) greater than 1.00 D

研究组 & 干预措施

Test Arm 2

Other

Single vision, impact-resistant spectacle lenses

干预措施: Spectacle lenses (Device)

SightGlass Vision Test Arm 1

Experimental

Single vision, impact-resistant spectacle lenses

干预措施: Novel spectacle lens design (Device)

结局指标

主要结局

Axial length

时间窗: 12 months

Change in axial length from baseline

次要结局

  • Axial length(24 months)
  • Axial length(36 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验